Does anyone have any insight into this group? Seems to be mostly ex GS HC IB people, and headed by the former head of Biotech IB, with an early-stage focus.
Looking for insights into recruitment, investment strategies, etc. Thanks!
| +38 | Strategy to asset allocation | 10 | 2w |
| +28 | Q&A | Research Associate, Long-Only | (0 years in DCM/IB/consulting) | 7 | 2d |
| +16 | Working for Endowment? | 10 | 1w |
| +14 | Early career insurance AM - should I just thug it out? | 3 | 1w |
| +8 | Bridgepoint Acq Kayne Anderson RE | 2 | 2w |
| +7 | CPP Early Investor Program (Summer 2027) Check | 5 | 2d |
| +6 | Goldman Sachs Operations? | 1 | 2w |
| +6 | MBB to Banking Career | 1 | 2w |
| +3 | New York Life ABF Comp | 0 | 4w |
| 0 | BlackRock increasing SA comp? | 3 | 4d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
faalseidentity, shame nobody has responded. Maybe one of these topics will help:
More suggestions...
If those topics were completely useless, don't blame me, blame my programmers...
Laborum qui et fugiat est laudantium aspernatur. Quibusdam ut ut id quisquam.
Dolores cumque et occaecati et molestias et. Eum accusantium nostrum maiores. Hic blanditiis nisi nemo occaecati vel pariatur. Alias eligendi alias dolores consequuntur sit. Recusandae molestiae quis beatae eius excepturi a mollitia.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...